Early discontinuation of adjuvant chemotherapy in patients with early-stage pancreatic cancer correlates with inferior survival: A multicenter population-based cohort studyJaveria Muhammadzai, Shahid Ahmed, Kamal Haider et al.|PLoS ONE|2022Cited by 11
Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28–29, October 2022Sharlene Gill, Karen Mulder, Howard J. Lim et al.|Current Oncology|2023Cited by 2
Systemic therapy with a loco-regional treatment in patients with locally advanced pancreatic cancer: The SMART study.Shahid Ahmed, Mike Moser, Osama Ahmed et al.|Journal of Clinical Oncology|2021Cited by 1
Correction: Gill et al. Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28–29, October 2022. Curr. Oncol. 2023, 30, 7964–7983Sharlene Gill, Karen Mulder, Shahid Ahmed et al.|Current Oncology|2024Cited by 1
Early Single-Center Experience With Irreversible Electroporation for Stage 2, 3, and 4 Pancreatic AdenocarcinomasChristopher J Wall, Mike Moser, Shahid Ahmed et al.|Pancreas|2022Cited by 1